| Literature DB >> 28798291 |
Ying Fu1, Nannan Wu1, Dong Zhao1.
Abstract
BACKGROUND The aim of this research was to study the function of NLRP3 in the pathogenesis and development of diabetic nephropathy (DN). MATERIAL AND METHODS We compared the expression of NLRP3-related protein in human glomerular mesangial cells under high glucose conditions at different times and in rats with DN of different ages. We also compared changes in IL-18 and IL-1β expression levels at different stages of DN. RESULTS After six hours, 12 hours, and 24 hours of high glucose stimulation, the secretion of IL-1β in human glomerular mesangial cells, compared to unstimulated cells, was 1.85-fold, 3.04-fold, and 4.14-fold; the expression of NLRP3 increased by 2.20-fold, 4.62-fold, and 8.32-fold; and the expression of caspase-1 was increased by 1.60-fold, 2.72-fold, and 3.67-fold. The expression levels of nephrin in eight-week-old and 12-week-old DN rats compared to 4-week rats were 49.60% and 21.20%, respectively. The IL-1β levels compared to four-week DN rats were 2.57-fold and 4.17-fold, respectively; NLRP3 levels were 1.29-fold and 2.17-fold respectively, and caspase-1 levels were 3.37-fold and 4.16-fold, respectively. The serum levels of IL-18 and IL-1β in the DN group were the highest at 218.53±30.69 pg/mL and 62.47±9.36 pg/mL, respectively; followed by the mild DN group at 177.07±32.88 pg/mL and 28.13±5.37 pg/mL, respectively, with the diabetic mellitus (DM) group having the lowest levels at 141.47±9.49 pg/mL and 15.53±3.26 pg/mL, respectively. The healthy control group levels were 99.40±22.72 pg/mL and 12.40±5.08 pg/mL, respectively. CONCLUSIONS NLRP3 and high glucose activation may participate in the occurrence and development of DN by mediating the inflammatory response.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28798291 PMCID: PMC5565226 DOI: 10.12659/msm.903269
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Clinical data of subjects in each group.
| Groups | N (case) | Age (year) | Male (case) | Alb (mg/L) | IL-18 (pg/ml) | IL-1β (pg/ml) |
|---|---|---|---|---|---|---|
| Healthy control group | 10 | 51.20±6.14 | 6 | 7.00±3.81 | 99.40±22.72 | 12.40±5.08 |
| Pure DM group | 15 | 55.27±7.24 | 9 | 11.27±3.56 | 141.47±9.49 | 15.53±3.26 |
| Mild DN group | 15 | 55.93±7.34 | 8 | 130.33±41.53 | 177.07±32.88 | 28.13±5.37 |
| Moderate and severe DN group | 15 | 55.20±7.05 | 9 | 298.33±51.00 | 218.53±30.69 | 62.47±9.36 |
| F | 1.212 | 9.856 | 161.010 | 35.279 | 137.598 | |
| P | 0.317 | 0.129 | 0.000 | 0.000 | 0.000 |
P<0.05, compared with healthy control group;
P<0.05, compared with pure DM group;
P<0.05, compared with mild DN group.
Figure 1Influence of high glucose on the expression of IL-1β, NLRP3, and caspase-1 in mesangial cells. (A) Proteins IL-1β, NLRP3, and caspase-1 determined by Western blot assay. (B) The relative change analysis of the Western blot result. * p<0.05, compared with 0 hours.
Figure 2Expression of nephrin in DN rats of different ages. (A) The protein nephrin determined by immunohistochemistry. (a–c) Nephrin expression of DN four-week rats, eight-week rats, and 12-week rats. (B) The expression of nephrin determined by Western blot assay. (C) Analysis of the result B. * p<0.05, compared with 4-week rats. Bar: 50 μm.
Figure 3Expression of NLRP3 inflammasome-related proteins in DN rats of different ages. (A) The NLRP3 and caspase-1 expression of DN rats determined by immunohistochemistry. (B) IL-1β, NLRP3 and caspase-1 determined by Western blot assay. (C) Analysis of the result of B. * p<0.05, compared with 4-week rats. Bar: 50 μm.